We found that variation in the CYP2C19 gene, psychiatric and trait-specific PGSs, including SCZ, MDD, ANX, BIP, BMI, SBP, and headaches, were associated with the likelihood of side effects across all antidepressants. The gene discussed is CYP2C19; the disease is major depressive disorder.